ALX ONCOLOGY ($ALXO) posted quarterly earnings results for Q1 2026 on Friday, May 8th. The company reported earnings of -$0.17 per share, beating estimates of -$0.22 by $0.05. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $ALXO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALX ONCOLOGY Insider Trading Activity
ALX ONCOLOGY insiders have traded $ALXO stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ALXO stock by insiders over the last 6 months:
- COREY S GOODMAN purchased 3,184,713 shares for an estimated $4,999,999
- JASON LETTMANN (CHIEF EXECUTIVE OFFICER) sold 12,311 shares for an estimated $26,714
- SHELLY PINTO (SVP, FINANCE AND CAO) has made 0 purchases and 2 sales selling 4,828 shares for an estimated $6,316.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
ALX ONCOLOGY Hedge Fund Activity
We have seen 24 institutional investors add shares of ALX ONCOLOGY stock to their portfolio, and 26 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERIPRISE FINANCIAL INC removed 652,897 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $737,773
- DRIEHAUS CAPITAL MANAGEMENT LLC added 627,105 shares (+78.8%) to their portfolio in Q4 2025, for an estimated $708,628
- MILLENNIUM MANAGEMENT LLC added 581,758 shares (+22.2%) to their portfolio in Q4 2025, for an estimated $657,386
- PRIVIUM FUND MANAGEMENT B.V. removed 509,059 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $575,236
- RENAISSANCE TECHNOLOGIES LLC added 258,600 shares (+157.2%) to their portfolio in Q4 2025, for an estimated $292,218
- ACADIAN ASSET MANAGEMENT LLC added 153,448 shares (+12.6%) to their portfolio in Q4 2025, for an estimated $173,396
- VANGUARD GROUP INC added 102,321 shares (+6.7%) to their portfolio in Q4 2025, for an estimated $115,622
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
ALX ONCOLOGY Price Targets
Multiple analysts have issued price targets for $ALXO recently. We have seen 3 analysts offer price targets for $ALXO in the last 6 months, with a median target of $4.0.
Here are some recent targets:
- Derek Archila from Wells Fargo set a target price of $5.0 on 03/19/2026
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $4.0 on 03/10/2026
- Allison Bratzel from Piper Sandler set a target price of $4.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
